$NBIX
NEUROCRINE BIOSCIENCES INC

2021 Q2 Form 10-Q Financial Statement

#000091447521000047 Filed on August 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $288.9M $302.4M $237.1M
YoY Change -4.46% 64.8% 71.32%
Cost Of Revenue $3.100M $2.400M $2.100M
YoY Change 29.17% 50.0% 86.01%
Gross Profit $285.8M $300.0M $235.0M
YoY Change -4.73% 64.93% 71.19%
Gross Profit Margin 98.93% 99.21% 99.11%
Selling, General & Admin $143.2M $96.50M $117.8M
YoY Change 48.39% 19.43% 34.57%
% of Gross Profit 50.1% 32.17% 50.13%
Research & Development $74.80M $80.90M $58.30M
YoY Change -7.54% 31.15% 54.84%
% of Gross Profit 26.17% 26.97% 24.81%
Depreciation & Amortization $2.600M $2.100M $2.100M
YoY Change 23.81% 16.67% 31.25%
% of Gross Profit 0.91% 0.7% 0.89%
Operating Expenses $218.0M $225.8M $178.2M
YoY Change -3.45% 51.44% -25.56%
Operating Profit $62.80M $76.60M $58.90M
YoY Change -18.02% 122.67% -158.32%
Interest Expense $6.200M $8.300M $8.200M
YoY Change -25.3% 5.06% 4.42%
% of Operating Profit 9.87% 10.84% 13.92%
Other Income/Expense, Net -$5.300M $6.600M -$20.00M
YoY Change -180.3% -62.71% 1152.35%
Pretax Income $57.50M $83.20M $38.90M
YoY Change -30.89% 59.69% -137.91%
Income Tax $15.20M $3.600M $1.500M
% Of Pretax Income 26.43% 4.33% 3.86%
Net Earnings $42.30M $79.60M $37.40M
YoY Change -46.86% 55.17% -136.63%
Net Earnings / Revenue 14.64% 26.32% 15.77%
Basic Earnings Per Share $0.45 $0.86 $0.40
Diluted Earnings Per Share $0.43 $0.81 $0.39
COMMON SHARES
Basic Shares Outstanding 94.60M shares 93.00M shares 92.60M shares
Diluted Shares Outstanding 97.70M shares 98.20M shares 97.00M shares

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $884.9M $948.3M $771.7M
YoY Change -6.69% 52.96% 47.25%
Cash & Equivalents $368.0M $415.1M $187.0M
Short-Term Investments $516.9M $533.2M $584.7M
Other Short-Term Assets $38.40M $27.50M $26.70M
YoY Change 39.64% 28.18% 10.56%
Inventory $28.30M $22.00M $21.20M
Prepaid Expenses
Receivables $158.5M $148.4M $148.6M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.110B $1.146B $968.2M
YoY Change -3.15% 53.07% 52.91%
LONG-TERM ASSETS
Property, Plant & Equipment $50.00M $44.60M $41.90M
YoY Change 12.11% 12.56% 14.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $376.7M $245.9M $275.3M
YoY Change 53.19% 9.83% 18.1%
Other Assets $3.200M $3.600M $3.200M
YoY Change -11.11% -34.55% -41.82%
Total Long-Term Assets $846.3M $369.4M $393.7M
YoY Change 129.1% 16.14% 21.31%
TOTAL ASSETS
Total Short-Term Assets $1.110B $1.146B $968.2M
Total Long-Term Assets $846.3M $369.4M $393.7M
Total Assets $1.956B $1.516B $1.362B
YoY Change 29.08% 42.06% 42.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $190.9M $137.1M $125.9M
YoY Change 39.24% 44.32% 84.33%
Accrued Expenses $15.00M $9.200M $8.800M
YoY Change 63.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $419.5M $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $212.9M $573.0M $140.3M
YoY Change -62.84% 469.64% 94.85%
LONG-TERM LIABILITIES
Long-Term Debt $326.3M $0.00 $414.1M
YoY Change -100.0% 5.26%
Other Long-Term Liabilities $29.00M $27.10M $21.60M
YoY Change 7.01% 51.27% 36.17%
Total Long-Term Liabilities $29.00M $27.10M $21.60M
YoY Change 7.01% 51.27% 36.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $212.9M $573.0M $140.3M
Total Long-Term Liabilities $29.00M $27.10M $21.60M
Total Liabilities $677.2M $684.4M $161.9M
YoY Change -1.05% 17.36% 84.26%
SHAREHOLDERS EQUITY
Retained Earnings -$651.0M -$1.016B
YoY Change -35.91% -16.78%
Common Stock $1.930B $1.842B
YoY Change 4.73% 8.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.279B $831.2M $700.3M
YoY Change
Total Liabilities & Shareholders Equity $1.956B $1.516B $1.362B
YoY Change 29.08% 42.06% 42.2%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $42.30M $79.60M $37.40M
YoY Change -46.86% 55.17% -136.63%
Depreciation, Depletion And Amortization $2.600M $2.100M $2.100M
YoY Change 23.81% 16.67% 31.25%
Cash From Operating Activities $103.2M $121.6M $35.50M
YoY Change -15.13% 89.41% -131.56%
INVESTING ACTIVITIES
Capital Expenditures -$4.300M -$4.700M $1.300M
YoY Change -8.51% 4.44% -66.67%
Acquisitions
YoY Change
Other Investing Activities -$86.50M $98.10M $34.50M
YoY Change -188.18% 2235.71% -23.16%
Cash From Investing Activities -$90.80M $93.40M $33.20M
YoY Change -197.22% -31233.33% -19.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.000M
YoY Change 130.77%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.000M 13.10M $6.000M
YoY Change -77.1% 204.65% 130.77%
NET CHANGE
Cash From Operating Activities 103.2M 121.6M $35.50M
Cash From Investing Activities -90.80M 93.40M $33.20M
Cash From Financing Activities 3.000M 13.10M $6.000M
Net Change In Cash 15.40M 228.1M $74.70M
YoY Change -93.25% 234.46% -208.42%
FREE CASH FLOW
Cash From Operating Activities $103.2M $121.6M $35.50M
Capital Expenditures -$4.300M -$4.700M $1.300M
Free Cash Flow $107.5M $126.3M $34.20M
YoY Change -14.89% 83.84% -129.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000914475
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-22705
dei Entity Registrant Name
EntityRegistrantName
NEUROCRINE BIOSCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address Address Line1
EntityAddressAddressLine1
12780 El Camino Real
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0525145
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
dei City Area Code
CityAreaCode
(858)
dei Local Phone Number
LocalPhoneNumber
617-7600
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
NBIX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
94646427 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
368000000.0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
187100000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
516300000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
612400000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
516900000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
613900000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
158500000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
157100000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
28300000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
28000000.0 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
38400000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
30100000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
1110100000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1016200000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
316100000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
319400000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Amortized Cost Noncurrent
DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
337900000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Amortized Cost Noncurrent
DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
226700000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
337800000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
227100000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
100300000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
82800000 USD
CY2021Q2 us-gaap Equity Securities Fv Ni Restricted
EquitySecuritiesFvNiRestricted
38900000 USD
CY2020Q4 us-gaap Equity Securities Fv Ni Restricted
EquitySecuritiesFvNiRestricted
38200000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50000000.0 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44600000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3200000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6400000 USD
CY2021Q2 us-gaap Assets
Assets
1956400000 USD
CY2020Q4 us-gaap Assets
Assets
1734700000 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
190900000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
168700000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
22000000.0 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17800000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
212900000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
186500000 USD
CY2021Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
326300000 USD
CY2020Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
317900000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
109000000.0 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
94400000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29000000.0 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9700000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
677200000 USD
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
94600000 shares
CY2020Q4 us-gaap Liabilities
Liabilities
608500000 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000.0 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000.0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
220000000.0 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
220000000.0 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
94600000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
93500000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
93500000 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1929400000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1849700000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
700000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1800000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-651000000.0 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-725400000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1279200000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1126200000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1956400000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1734700000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
288900000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
302400000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
525500000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
539500000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3100000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2400000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6000000.0 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4500000 USD
CY2021Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
74800000 USD
CY2020Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
80900000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
148000000.0 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
139200000 USD
CY2021Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
5000000.0 USD
CY2020Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
46000000.0 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
5000000.0 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
46000000.0 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
143200000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
96500000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
272200000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
214300000 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
226100000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
225800000 USD
us-gaap Costs And Expenses
CostsAndExpenses
431200000 USD
us-gaap Costs And Expenses
CostsAndExpenses
404000000.0 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
62800000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
76600000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
94300000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
135500000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
6200000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
8300000 USD
us-gaap Interest Expense
InterestExpense
12600000 USD
us-gaap Interest Expense
InterestExpense
16500000 USD
CY2021Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 USD
CY2020Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
11300000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
700000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-5200000 USD
CY2021Q2 nbix Investment Income And Other Net
InvestmentIncomeAndOtherNet
900000 USD
CY2020Q2 nbix Investment Income And Other Net
InvestmentIncomeAndOtherNet
3600000 USD
nbix Investment Income And Other Net
InvestmentIncomeAndOtherNet
2300000 USD
nbix Investment Income And Other Net
InvestmentIncomeAndOtherNet
8300000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5300000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6600000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9600000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13400000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
57500000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
83200000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
84700000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
122100000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15200000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5100000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
42300000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
79600000 USD
us-gaap Net Income Loss
NetIncomeLoss
74400000 USD
us-gaap Net Income Loss
NetIncomeLoss
117000000.0 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-300000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
6000000.0 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1100000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3200000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
42000000.0 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
85600000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
73300000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
120200000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.26
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94600000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93000000.0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92800000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97700000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98200000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97600000 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1205600000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
42300000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-300000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28600000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3000000.0 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1279200000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
700300000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
79600000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000000.0 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29500000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15800000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
831200000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1126200000 USD
us-gaap Net Income Loss
NetIncomeLoss
74400000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1100000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
61500000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
18200000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1279200000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
636900000 USD
us-gaap Net Income Loss
NetIncomeLoss
117000000.0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3200000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
52300000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
21800000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
831200000 USD
us-gaap Net Income Loss
NetIncomeLoss
74400000 USD
us-gaap Net Income Loss
NetIncomeLoss
117000000.0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
61500000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
52300000 USD
us-gaap Depreciation
Depreciation
5100000 USD
us-gaap Depreciation
Depreciation
4200000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
7900000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
10000000.0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
600000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
700000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
700000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-5200000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
3300000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
5600000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
700000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1400000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21800000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
300000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4700000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
29000000.0 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5100000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-5500000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
4100000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
190500000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
154400000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
383100000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
288600000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
364200000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
421200000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8800000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6000000.0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27700000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
126600000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18200000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
21800000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
100000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18100000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21800000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
180900000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
302800000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
190300000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115500000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
371200000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
418300000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2200000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
900000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
21600000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Interest Paid Net
InterestPaidNet
4300000 USD
us-gaap Interest Paid Net
InterestPaidNet
5800000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1600000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
nbix Number Of Irish Subsidiaries
NumberOfIrishSubsidiaries
2 subsidiary
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
245500000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
300000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
245500000 USD
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
300000 USD
CY2021Q2 nbix Debt Securities Available For Sale Position Number Of Positions
DebtSecuritiesAvailableForSalePositionNumberOfPositions
142 security
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
56 security
CY2021Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
2700000 USD
CY2020Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
3700000 USD
us-gaap Debt Securities Available For Sale Accrued Interest Writeoff
DebtSecuritiesAvailableForSaleAccruedInterestWriteoff
0 USD
us-gaap Debt Securities Available For Sale Accrued Interest Writeoff
DebtSecuritiesAvailableForSaleAccruedInterestWriteoff
0 USD
CY2021Q2 us-gaap Investments
Investments
1264800000 USD
CY2020Q4 us-gaap Investments
Investments
1069500000 USD
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
14200000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
16600000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2600000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2400000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
11500000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9000000.0 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
28300000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
28000000.0 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
368000000.0 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
415100000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3200000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3200000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
371200000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
418300000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3200000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
7300000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
5000000.0 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
5500000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
4300000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y2M12D
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.053
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.058
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7100000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
16800000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
17500000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
17000000.0 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
15500000 USD
CY2021Q2 nbix Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
85400000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
159300000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
35300000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
124000000.0 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15000000.0 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
109000000.0 USD
CY2021Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
381200000 USD
CY2020Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
381300000 USD
CY2021Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3400000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
4000000.0 USD
CY2021Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
51500000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
59400000 USD
CY2021Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
326300000 USD
CY2020Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
317900000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
42300000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
79600000 USD
us-gaap Net Income Loss
NetIncomeLoss
74400000 USD
us-gaap Net Income Loss
NetIncomeLoss
117000000.0 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94600000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93000000.0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92800000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97700000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98200000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.26
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97600000 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.86
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4700000 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2200000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3700000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1400000 shares

Files In Submission

Name View Source Status
0000914475-21-000047-index-headers.html Edgar Link pending
0000914475-21-000047-index.html Edgar Link pending
0000914475-21-000047.txt Edgar Link pending
0000914475-21-000047-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nbix-20210630.htm Edgar Link pending
nbix-20210630.xsd Edgar Link pending
nbix-20210630exhibit311.htm Edgar Link pending
nbix-20210630exhibit312.htm Edgar Link pending
nbix-20210630exhibit32.htm Edgar Link pending
nbix-20210630_cal.xml Edgar Link unprocessable
nbix-20210630_def.xml Edgar Link unprocessable
nbix-20210630_htm.xml Edgar Link completed
nbix-20210630_lab.xml Edgar Link unprocessable
nbix-20210630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending